Roundtable: Focus on DLBCL

A collection of roundtable discussions focused on important news and updates in diffuse large B-cell lymphoma.

Advertisement
Advertisement
Tara Graff, DO, MSAggressive B-Cell Lymphoma | March 10, 2025
The expert panel describes outstanding clinical research needs in DLBCL and what research underway they find exciting.
Tara Graff, DO, MSAggressive B-Cell Lymphoma | March 10, 2025
Expert clinicians describe which factors they consider when selecting between these two interventions for DLBCL management.
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
An expert panel discusses utilizing molecular strategies to determine treatment decisions for DLBCL.
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
In this DLBCL roundtable, experts share which novel agents or combinations they are most interested in.
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
Ruemu Birhiray, MD, leads an expert roundtable on the current treatment pathway in DLBCL.
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
The expert panel assesses the current and expected utility for clinicians of MRD in DLBCL management decisions.
Advertisement
Advertisement